Beemnet W. Dada

Array ( [id] => 1014734 [patent_doc_number] => 06894077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Preventive or remedy for hypertension' [patent_app_type] => utility [patent_app_number] => 10/161739 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4578 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894077.pdf [firstpage_image] =>[orig_patent_app_number] => 10161739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631281 [patent_doc_number] => 06635651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-21 [patent_title] => 'Inhibitors of thrombin induced platelet aggregation' [patent_app_type] => B2 [patent_app_number] => 10/157474 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6237 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635651.pdf [firstpage_image] =>[orig_patent_app_number] => 10157474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5907903 [patent_doc_number] => 20020142943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Modifying the permeability of physiological barriers' [patent_app_type] => new [patent_app_number] => 10/154896 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8395 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142943.pdf [firstpage_image] =>[orig_patent_app_number] => 10154896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037573 [patent_doc_number] => 06872722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Therapies for tissue damage resulting from ischemia' [patent_app_type] => utility [patent_app_number] => 10/154694 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10375 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872722.pdf [firstpage_image] =>[orig_patent_app_number] => 10154694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750994 [patent_doc_number] => 20030045515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Combination medicament for treatment of neoplastic diseases' [patent_app_type] => new [patent_app_number] => 10/151094 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7165 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045515.pdf [firstpage_image] =>[orig_patent_app_number] => 10151094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870640 [patent_doc_number] => 20030083330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Pharmaceutically active morpholinol' [patent_app_type] => new [patent_app_number] => 10/150287 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4694 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083330.pdf [firstpage_image] =>[orig_patent_app_number] => 10150287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609789 [patent_doc_number] => 06998400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Pharmaceutically active morpholinol' [patent_app_type] => utility [patent_app_number] => 10/150341 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5326 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998400.pdf [firstpage_image] =>[orig_patent_app_number] => 10150341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274718 [patent_doc_number] => 06649630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-18 [patent_title] => 'Methods and compositions controlling pests' [patent_app_type] => B2 [patent_app_number] => 10/147455 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3342 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649630.pdf [firstpage_image] =>[orig_patent_app_number] => 10147455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056596 [patent_doc_number] => 06855820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Pharmaceutically active morpholinol' [patent_app_type] => utility [patent_app_number] => 10/147588 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6428 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855820.pdf [firstpage_image] =>[orig_patent_app_number] => 10147588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1096377 [patent_doc_number] => 06821970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Oxazinocarbazoles for the treatment of CNS diseases' [patent_app_type] => B2 [patent_app_number] => 10/146970 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20529 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 661 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821970.pdf [firstpage_image] =>[orig_patent_app_number] => 10146970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637954 [patent_doc_number] => 07125909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Sterile parenteral nutrition compositions' [patent_app_type] => utility [patent_app_number] => 10/143808 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4745 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125909.pdf [firstpage_image] =>[orig_patent_app_number] => 10143808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413102 [patent_doc_number] => 20020183277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Combination of vitamin D analogue and pyrimidine nucleoside analogue' [patent_app_type] => new [patent_app_number] => 10/142778 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5581 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183277.pdf [firstpage_image] =>[orig_patent_app_number] => 10142778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262076 [patent_doc_number] => 20020187999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Anti-inflammatory uses of manzamines' [patent_app_type] => new [patent_app_number] => 10/144888 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4942 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187999.pdf [firstpage_image] =>[orig_patent_app_number] => 10144888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 715912 [patent_doc_number] => 07053072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Methods for the administration of amifostine and related compounds' [patent_app_type] => utility [patent_app_number] => 10/140108 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18068 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053072.pdf [firstpage_image] =>[orig_patent_app_number] => 10140108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451433 [patent_doc_number] => 20020177611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Pharmaceutical formulation comprising glycine as a stabilizer' [patent_app_type] => new [patent_app_number] => 10/137331 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4415 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177611.pdf [firstpage_image] =>[orig_patent_app_number] => 10137331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1307350 [patent_doc_number] => 06617321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-09 [patent_title] => '2-methyl-thieno-benzodiazepine formulation' [patent_app_type] => B2 [patent_app_number] => 10/136887 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12449 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617321.pdf [firstpage_image] =>[orig_patent_app_number] => 10136887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788285 [patent_doc_number] => 20020160935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Use of leptin antagonists for the treatment of diabetes' [patent_app_type] => new [patent_app_number] => 10/133285 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2812 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160935.pdf [firstpage_image] =>[orig_patent_app_number] => 10133285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664613 [patent_doc_number] => 20030203939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR HEPATOPROTECTION AND TREATMENT OF CHOLESTASIS' [patent_app_type] => new [patent_app_number] => 10/132311 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4306 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203939.pdf [firstpage_image] =>[orig_patent_app_number] => 10132311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7631268 [patent_doc_number] => 06635664 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Insecticide compositions and method for destroying insects' [patent_app_type] => B1 [patent_app_number] => 10/111315 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3776 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635664.pdf [firstpage_image] =>[orig_patent_app_number] => 10111315 [rel_patent_id] =>[rel_patent_doc_number] =>)